Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.4% of adults in Buffalo have diagnosed diabetes — 1.4 points above the U.S. 12% figure. Census population 278,349. New York Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Buffalo clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Buffalo storefront.
361 HCT/P Compliant Tissue Products in Buffalo, NY for clinics & physicians. Exclusively 361 HCT/P complia… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of 361 hctp compliant products in Buffalo: (1) CDC PLACES (2023, crude) estimates 13.4% of adults in Buffalo have diagnosed diabetes — 1.4 points above the U.S. 12% figure. (2) New York Part B wound biologics are reviewed by National Government Services (NGS) under JK, shared with CT, MA, ME, NH, RI, VT. We help with the second file. We do not pretend to be a Buffalo storefront.
National 361 HCT/P Compliant Tissue Products notes (how the product actually works)New York shares JK with CT, MA, ME, NH, RI, VT. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 13.4% of adults in Buffalo have diagnosed diabetes — 1.4 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 13.4% of adults in Buffalo have diagnosed diabetes — 1.4 points above the U.S. 12% figure. Adult arthritis here is 25.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Buffalo.
CDC PLACES (2023, crude prevalence) estimates 13.4% of adults — 1.4 points above the U.S. 12% figure. Obesity is 38.4%; arthritis is 25.3%. That is place-level BRFSS modeling, not a clinic census and not a Buffalo trial.
New York is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
New York is JK. A sister clinic in another state may be a different contractor with different CTP articles. Do not assume one utilization policy ports. We map both if you operate across MACs.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. National Government Services (NGS) LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
Bring specialty, monthly joint / regenerative volume, and whether you bill JK FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 13.4% diabetes and 25.3% arthritis for Buffalo — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Buffalo, NY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Buffalo is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Buffalo — 1.4 points above the U.S. 12% figure. Planning input, not an outcomes claim.
New York Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Buffalo. Useful for joint-program math; still needs a diagnosis and privileging.
No Buffalo storefront. Joe Bradley is an active practice owner. 361 hctp compliant products stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.